Navidea Biopharmaceuticals Inc Stock Forecast
Big movements in Navidea Biopharmaceuticals Inc stock price on Friday moving 14.14% between high and low
(Updated on May 03, 2024)
The Navidea Biopharmaceuticals Inc stock price gained 9.29% on the last trading day (Friday, 3rd May 2024), rising from $0.0350 to $0.0383. During the last trading day the stock fluctuated 14.14% from a day low at $0.0350 to a day high of $0.0400. The price has risen in 6 of the last 10 days and is up by 9.29% over the past 2 weeks. Volume fell on the last day by -16 thousand shares and in total, 3 thousand shares were bought and sold for approximately $128.64 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.44% during the next 3 months and, with a 90% probability hold a price between $0.0283 and $0.0451 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
NAVB Signals & Forecast
There are mixed signals in the stock today. The Navidea Biopharmaceuticals Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0388. On a fall, the stock will find some support from the short-term average at $0.0364. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Monday, April 29, 2024, and so far it has risen 9.29%. Further rise is indicated until a new top pivot has been found.
Support, Risk & Stop-loss for Navidea Biopharmaceuticals Inc stock
Navidea Biopharmaceuticals Inc finds support from accumulated volume at $0.0380 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0050 between high and low, or 14.14%. For the last week the stock has had daily average volatility of 42.82%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (NAVB) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Navidea Biopharmaceuticals Inc to open at $0.0377, and during the day (based on 14 day Average True Range), to move between $0.0280 and $0.0485, which gives a possible trading interval of +/-$0.0102 (+/-26.73%) up or down from last closing price. If Navidea Biopharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 53.46% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.0380 (0.65%) than the resistance at $0.0395 (3.27%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Navidea Biopharmaceuticals Inc stock A Buy?
Navidea Biopharmaceuticals Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -2.867 Sell Candidate Unchanged
Predicted Opening Price for Navidea Biopharmaceuticals Inc of Monday, May 6, 2024
Fair opening price May 6, 2024 | Current price |
---|---|
$0.0377 ( 1.35%) | $0.0383 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for NAVB
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0.0427 | 11.59 % | |
R2 | 0.0408 | 6.65 % | ||
R1 | 0.0396 | 3.59 % | ||
Current price: | 0.0383 | |||
Support | S1 | 0.0358 | -6.29 % | |
S2 | 0.0347 | -9.35 % | ||
S3 | 0.0328 | -14.29 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0.0452 | 18.04 % | |
R2 | 0.0400 | 4.58 % | ||
R1 | 0.0395 | 3.27 % | ||
Current price | 0.0383 | |||
Support | S1 | 0.0380 | -0.654% | |
S2 | 0.0350 | -8.50% | ||
S3 | 0.0345 | -9.80% |
FAQ
Click here for our free guide on how to buy Navidea Biopharmaceuticals Inc Stock.